候选药物-话题@MedSci - 梅斯（MedSci）

#候选药物#

51篇内容 | 2109人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2052419, encodeId=7de0205241990, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Bicycle Therapeutics宣布与英国癌症研究中心合作开发新型肿瘤免疫学候选药物——多价CD137激动剂BT7401, objectType=article, longId=185937, objectId=58ff18593e64, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ff18593e64, replyNumber=0, likeNumber=71, createdTime=2020-11-26, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ff18593e64, moduleTitle=Bicycle Therapeutics宣布与英国癌症研究中心合作开发新型肿瘤免疫学候选药物——多价CD137激动剂BT7401, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=58ff18593e64)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052424, encodeId=f43b205242404, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=American Journal of Pathology：研究发现糖尿病视网膜病变候选药物, objectType=article, longId=193207, objectId=316f19320e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=316f19320e5f, replyNumber=0, likeNumber=79, createdTime=2021-02-15, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=316f19320e5f, moduleTitle=American Journal of Pathology：研究发现糖尿病视网膜病变候选药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=316f19320e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052415, encodeId=1f212052415fb, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=罗氏同意以14亿美元收购Promedior，获得肺纤维化和骨髓纤维化II期候选药物, objectType=article, longId=183197, objectId=fe4e18319eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4e18319eb6, replyNumber=0, likeNumber=88, createdTime=2019-12-24, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4e18319eb6, moduleTitle=罗氏同意以14亿美元收购Promedior，获得肺纤维化和骨髓纤维化II期候选药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe4e18319eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052420, encodeId=aac22052420ad, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=礼来终止与NextCure公司一年前签订的14亿美元合作协议，后者候选药物为靶向M2巨噬细胞表面的Siglec-15单抗, objectType=article, longId=186460, objectId=2b971864609d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b971864609d, replyNumber=0, likeNumber=63, createdTime=2020-12-03, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b971864609d, moduleTitle=礼来终止与NextCure公司一年前签订的14亿美元合作协议，后者候选药物为靶向M2巨噬细胞表面的Siglec-15单抗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b971864609d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052421, encodeId=bc6e20524216b, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, objectType=article, longId=186520, objectId=88ea186520c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ea186520c4, replyNumber=0, likeNumber=98, createdTime=2020-02-13, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ea186520c4, moduleTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88ea186520c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052418, encodeId=7ceb205241843, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Brit J Cancer：重定位筛选鉴定了甲苯咪唑可作为临床候选药物协同多烯紫杉醇治疗前列腺癌, objectType=article, longId=185469, objectId=e624185469b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e624185469b0, replyNumber=0, likeNumber=108, createdTime=2020-06-27, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e624185469b0, moduleTitle=Brit J Cancer：重定位筛选鉴定了甲苯咪唑可作为临床候选药物协同多烯紫杉醇治疗前列腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e624185469b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052414, encodeId=709b205241406, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=IRLAB的候选药物IRL942和IRL1009已在美国和欧洲获得专利, objectType=article, longId=182549, objectId=507f182549da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507f182549da, replyNumber=0, likeNumber=58, createdTime=2020-07-16, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507f182549da, moduleTitle=IRLAB的候选药物IRL942和IRL1009已在美国和欧洲获得专利, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=507f182549da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052416, encodeId=adf9205241664, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=PNAS发文揭示治疗多发性骨髓瘤和三阴性乳腺癌的潜在药物靶点和候选药物分子, objectType=article, longId=184311, objectId=02b2184311ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b2184311ca, replyNumber=0, likeNumber=78, createdTime=2020-05-25, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b2184311ca, moduleTitle=PNAS发文揭示治疗多发性骨髓瘤和三阴性乳腺癌的潜在药物靶点和候选药物分子, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02b2184311ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052417, encodeId=1130205241ee1, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=百时美施贵宝和蓝鸟生物报告其CAR-T细胞疗法候选药物idecabtagene vicleucel的阳性结果, objectType=article, longId=184397, objectId=4dad18439e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dad18439e2a, replyNumber=0, likeNumber=65, createdTime=2020-03-25, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dad18439e2a, moduleTitle=百时美施贵宝和蓝鸟生物报告其CAR-T细胞疗法候选药物idecabtagene vicleucel的阳性结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4dad18439e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052413, encodeId=c56d205241300, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Alkermes的精神分裂症候选药物ALKS 3831将扩大向FDA的营销申请，以用于治疗I型双相情感障碍, objectType=article, longId=175616, objectId=69861e5616fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69861e5616fe, replyNumber=0, likeNumber=79, createdTime=2019-09-15, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69861e5616fe, moduleTitle=Alkermes的精神分裂症候选药物ALKS 3831将扩大向FDA的营销申请，以用于治疗I型双相情感障碍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=69861e5616fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052411, encodeId=fa802052411f8, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定, objectType=article, longId=164117, objectId=60a716411e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60a716411e78, replyNumber=0, likeNumber=75, createdTime=2019-07-28, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60a716411e78, moduleTitle=囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=60a716411e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052412, encodeId=f38d205241293, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=J Med Chem：发现新型抗血栓候选药物58l, objectType=article, longId=164321, objectId=a577164321eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a577164321eb, replyNumber=0, likeNumber=76, createdTime=2020-02-03, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a577164321eb, moduleTitle=J Med Chem：发现新型抗血栓候选药物58l, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a577164321eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052408, encodeId=1b472052408d5, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Redx Pharma宣布新的肺纤维化候选药物RXC006, objectType=article, longId=153632, objectId=d53b15363299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d53b15363299, replyNumber=0, likeNumber=64, createdTime=2019-07-20, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d53b15363299, moduleTitle=Redx Pharma宣布新的肺纤维化候选药物RXC006, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d53b15363299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052406, encodeId=6d74205240670, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Biois的阿尔茨海默氏症候选药物Eisai在PhII试验中表现出了希望, objectType=article, longId=142763, objectId=7a16142e6318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a16142e6318, replyNumber=0, likeNumber=53, createdTime=2018-12-04, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a16142e6318, moduleTitle=Biois的阿尔茨海默氏症候选药物Eisai在PhII试验中表现出了希望, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7a16142e6318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052410, encodeId=13372052410f1, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=J Med Chem：发现新型抗MRSA候选药物, objectType=article, longId=163166, objectId=a53516316660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a53516316660, replyNumber=0, likeNumber=78, createdTime=2019-07-23, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a53516316660, moduleTitle=J Med Chem：发现新型抗MRSA候选药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a53516316660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052409, encodeId=5ba5205240926, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=Mannin Research与麦克马斯特大学合作眼部靶向输送候选药物MAN-01：治疗青光眼, objectType=article, longId=159000, objectId=4af1159000f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4af1159000f7, replyNumber=0, likeNumber=97, createdTime=2019-08-11, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4af1159000f7, moduleTitle=Mannin Research与麦克马斯特大学合作眼部靶向输送候选药物MAN-01：治疗青光眼, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4af1159000f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052405, encodeId=6a8320524056d, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=vTv Therapeutics公司阿尔茨海默症候选药物临床试验失败, objectType=article, longId=135139, objectId=8b85135139e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b85135139e4, replyNumber=0, likeNumber=77, createdTime=2018-05-26, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b85135139e4, moduleTitle=vTv Therapeutics公司阿尔茨海默症候选药物临床试验失败, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8b85135139e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052407, encodeId=c374205240e99, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=A1M Pharma的候选药物ROSgard临床前研究显示出对急性肾损伤的强大保护作用, objectType=article, longId=146436, objectId=3dfe14643669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfe14643669, replyNumber=0, likeNumber=65, createdTime=2019-07-20, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfe14643669, moduleTitle=A1M Pharma的候选药物ROSgard临床前研究显示出对急性肾损伤的强大保护作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3dfe14643669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052403, encodeId=c7922052403fd, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=J Med Chem：上海药物所报道抗万古霉素耐药菌候选药物, objectType=article, longId=125764, objectId=4d2b125e6442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d2b125e6442, replyNumber=0, likeNumber=66, createdTime=2018-06-30, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d2b125e6442, moduleTitle=J Med Chem：上海药物所报道抗万古霉素耐药菌候选药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4d2b125e6442)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052404, encodeId=2e8720524044f, content=<a href='/topic/show?id=688a2e469f0' target=_blank style='color:#2F92EE;'>#候选药物#</a>, objectTitle=AZ收购了Ionis的NASH候选药物, objectType=article, longId=134876, objectId=852e1348e68f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=852e1348e68f, replyNumber=0, likeNumber=55, createdTime=2019-01-05, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=852e1348e68f, moduleTitle=AZ收购了Ionis的NASH候选药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=852e1348e68f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

候选药物

2020-05-29

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Bicycle Therapeutics宣布与英国癌症研究中心合作开发新型肿瘤免疫学候选药物——多价CD137激动剂BT7401

2020-11-26

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

American Journal of Pathology：研究发现糖尿病视网膜病变候选药物

2021-02-15

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

罗氏同意以14亿美元收购Promedior，获得肺纤维化和骨髓纤维化II期候选药物

2019-12-24

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

礼来终止与NextCure公司一年前签订的14亿美元合作协议，后者候选药物为靶向M2巨噬细胞表面的Siglec-15单抗

2020-12-03

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展

2020-02-13

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Brit J Cancer：重定位筛选鉴定了甲苯咪唑可作为临床候选药物协同多烯紫杉醇治疗前列腺癌

2020-06-27

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

IRLAB的候选药物IRL942和IRL1009已在美国和欧洲获得专利

2020-07-16

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

PNAS发文揭示治疗多发性骨髓瘤和三阴性乳腺癌的潜在药物靶点和候选药物分子

2020-05-25

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

百时美施贵宝和蓝鸟生物报告其CAR-T细胞疗法候选药物idecabtagene vicleucel的阳性结果

2020-03-25

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Alkermes的精神分裂症候选药物ALKS 3831将扩大向FDA的营销申请，以用于治疗I型双相情感障碍

2019-09-15

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定

2019-07-28

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

J Med Chem：发现新型抗血栓候选药物58l

2020-02-03

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Redx Pharma宣布新的肺纤维化候选药物RXC006

2019-07-20

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Biois的阿尔茨海默氏症候选药物Eisai在PhII试验中表现出了希望

2018-12-04

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

J Med Chem：发现新型抗MRSA候选药物

2019-07-23

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

Mannin Research与麦克马斯特大学合作眼部靶向输送候选药物MAN-01：治疗青光眼

2019-08-11

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

vTv Therapeutics公司阿尔茨海默症候选药物临床试验失败

2018-05-26

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

A1M Pharma的候选药物ROSgard临床前研究显示出对急性肾损伤的强大保护作用

2019-07-20

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

J Med Chem：上海药物所报道抗万古霉素耐药菌候选药物

2018-06-30

yuanming7 (审核中...)

前往app查看评论内容

#候选药物#

AZ收购了Ionis的NASH候选药物

2019-01-05

科室
- - 订阅+
  - 更多科室
工具
服务